Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.02 is in line with its 4-year average of 0.98, around the middle of its 4-year range (0.00–1.81).
As of the fiscal period ended Tuesday, June 30, 2026. 15.56% below its 12-month average of 1.21.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.02.
CURRENT RATIO
1.02
CURRENT RATIO AVG TTM
1.21
CURRENT RATIO AVG 3Y
1.36
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.56%
CURRENT VS 3Y AVG
-24.69%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
1.54
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-33.68%
vs the sector median at left
Market Cap
$13.19B
Current Ratio
1.35
TTM Avg
1.35
3Y Avg
1.39
5Y Avg
1.37
Market Cap
$18.02B
Current Ratio
1.69
TTM Avg
1.94
3Y Avg
1.85
5Y Avg
1.80
Market Cap
$12.54B
Current Ratio
1.95
TTM Avg
1.83
3Y Avg
1.71
5Y Avg
1.91
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.51B | 1.02 | 1.21 | 1.36 | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.27B | 0.73 | 0.83 | 0.68 | 0.84 |
| Exelixis, Inc. (EXEL)vs › | $14.56B | 3.46 | 3.59 | 3.51 | 4.19 |
| Revvity, Inc. (RVTY)vs › | $13.61B | 1.80 | 2.64 | 2.37 | 2.14 |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.19B | 1.35 | 1.35 | 1.39 | 1.37 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.02B | 1.69 | 1.94 | 1.85 | 1.80 |
| Baxter International Inc. (BAX)vs › | $12.54B | 1.95 | 1.83 | 1.71 | 1.91 |
| Penumbra, Inc. (PEN)vs › | $12.57B | 5.75 | 6.32 | 5.98 | 5.88 |
| Viatris Inc. (VTRS)vs › | $18.90B | 1.58 | 1.48 | 1.55 | 1.42 |
| Encompass Health Corporation (EHC)vs › | $12.08B | 1.19 | 1.06 | 1.17 | 1.20 |
Current Ratio
1.02
Quick Ratio
0.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.02 |
| 2026-03-31 | 1.07 |
| 2025-12-31 | 1.23 |
| 2025-09-30 | 1.50 |
| 2025-06-30 | 1.22 |
| 2025-03-31 | 1.19 |
| 2024-12-31 | 1.20 |
| 2024-09-30 | 1.15 |
| 2024-06-30 | 1.31 |
| 2024-03-31 | 1.81 |
| 2023-12-31 | 1.46 |
| 2023-09-30 | 1.81 |
| 2023-06-30 | 1.65 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
